Document is current

Article History

Received: 17 July 2020

Accepted: 15 March 2021

First Online: 8 April 2021

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki. This study did not require approval by any ethics committee as according to the Spanish law (“Ley 14/2007, de 3 de julio, de Investigación biomédica”).According to the Spanish law (“Ley 41/2002, de 14 de noviembre, básica reguladora de la autonomía del paciente y de derechos y obligaciones en materia de información y documentación clínica el consentimiento informado”), the informed consent has to be signed only when the activity of the study can affect patient’s health status. Since our study is an observational research, conducted through interviews with health care professionals, it was not necessary for patients to sign an informed consent in this study.

: Not applicable.

: MRA-S reports speakers’ fees from Roche, Shire, Grifols, Janssen, GSK, Merck, Abbvie, Leo-Pharma and Vertex, and non-financial support from Roche and Janssen. JMGdeC reports speakers’ fees from MSD, Roche, Alexion and Novartis, and travel expenses from MSD. JAL has received speakers’ fees from ROCHE. CMC reports speakers’ fees and travel expenses from Roche. AS has received honoraria and speakers’ fees from Roche, Jannsen and Celgene and travel expenses from Roche and Celgene. All other authors declare that they have no competing interest.